CYTOKINETICS INC — insider transactions
39 transactions on record · CYTK · CIK 1061983
Aggregates
computed from the filings belowPurchases, 12m
0
count of open-market buys
Sales, 12m
39
count of open-market sales
Buy / sell ratio, 12m
0.00
purchases per sale
Distinct insiders, 12m
9
Bought, 3m
$0
Sold, 3m
$4.2M
Median disclosure lag
0.0 d
trade date to filing date
Largest single trade, 24m
$1.1M
2026-07-30
Director share, 12m
53.8%
of transactions where role is stated
Current run
39 sells
consecutive same-direction transactions
Net 3m flow
-$4.2M
purchases minus sales
Total on record
39
Transactions
39 most recent shown| Disclosed | Recorded (UTC) | Traded | Lag, d | Insider | Role | Transaction | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-11-02 | 2026-11-03 03:32:55.323 UTC | 2026-11-02 | 0 | Blum Robert I | Director, CEO | Exercise of derivative | 7,500 | $0.00 | — | filing |
| 2026-11-02 | 2026-11-03 03:32:55.323 UTC | 2026-11-02 | 0 | Blum Robert I | Director, CEO | Open market sale | 7,500 | $62.81 | $471.1K | filing |
| 2026-11-02 | 2026-11-03 03:32:55.323 UTC | 2026-11-02 | 0 | Blum Robert I | Director, CEO | Exercise of derivative | 7,500 | $10.60 | $79.5K | filing |
| 2026-10-20 | 2026-10-21 02:30:24.836 UTC | 2026-10-20 | 0 | Malik Fady Ibraham | Development | Open market sale | 3,500 | $64.01 | $224K | filing |
| 2026-10-20 | 2026-10-21 02:30:25.325 UTC | 2026-10-16 | 4 | WIERENGA WENDELL | Director | Grant or award | 97 | $63.92 | $6.2K | filing |
| 2026-10-20 | 2026-10-21 02:30:25.813 UTC | 2026-10-16 | 4 | Kaye Edward M. MD | Director | Grant or award | 195 | $63.92 | $12.5K | filing |
| 2026-10-20 | 2026-10-21 02:30:24.836 UTC | 2026-10-20 | 0 | Malik Fady Ibraham | Development | Exercise of derivative | 3,500 | $0.00 | — | filing |
| 2026-10-20 | 2026-10-21 02:30:25.416 UTC | 2026-10-16 | 4 | Daly James M | Director | Grant or award | 195 | $63.92 | $12.5K | filing |
| 2026-10-20 | 2026-10-21 02:30:26.015 UTC | 2026-10-16 | 4 | Wysenski Nancy | Director | Grant or award | 97 | $63.92 | $6.2K | filing |
| 2026-10-20 | 2026-10-21 02:30:24.836 UTC | 2026-10-20 | 0 | Malik Fady Ibraham | Development | Exercise of derivative | 3,500 | $7.80 | $27.3K | filing |
| 2026-10-20 | 2026-10-21 02:30:25.249 UTC | 2026-10-16 | 4 | HENDERSON JOHN T | Director | Grant or award | 352 | $63.92 | $22.5K | filing |
| 2026-10-20 | 2026-10-21 02:30:25.615 UTC | 2026-10-16 | 4 | Harrington Robert Arthur | Director | Grant or award | 195 | $63.92 | $12.5K | filing |
| 2026-10-13 | 2026-10-14 02:54:20.007 UTC | 2026-10-12 | 1 | Blum Robert I | Director, CEO | Open market sale | 7,500 | $62.88 | $471.6K | filing |
| 2026-10-13 | 2026-10-14 02:54:20.007 UTC | 2026-10-12 | 1 | Blum Robert I | Director, CEO | Exercise of derivative | 7,500 | $10.60 | $79.5K | filing |
| 2026-10-13 | 2026-10-14 02:54:20.007 UTC | 2026-10-12 | 1 | Blum Robert I | Director, CEO | Exercise of derivative | 7,500 | $0.00 | — | filing |
| 2026-10-06 | 2026-10-07 06:20:02.242 UTC | 2026-10-06 | 0 | Malik Fady Ibraham | Development | Open market sale | 3,500 | $61.38 | $214.8K | filing |
| 2026-10-06 | 2026-10-07 06:20:02.242 UTC | 2026-10-06 | 0 | Malik Fady Ibraham | Development | Exercise of derivative | 3,500 | $7.80 | $27.3K | filing |
| 2026-10-06 | 2026-10-07 06:20:02.242 UTC | 2026-10-06 | 0 | Malik Fady Ibraham | Development | Exercise of derivative | 3,500 | $0.00 | — | filing |
| 2026-09-08 | 2026-09-09 02:34:06.066 UTC | 2026-09-08 | 0 | Malik Fady Ibraham | Development | Open market sale | 3,500 | $75.46 | $264.1K | filing |
| 2026-09-08 | 2026-09-09 02:34:06.066 UTC | 2026-09-08 | 0 | Malik Fady Ibraham | Development | Exercise of derivative | 3,500 | $7.80 | $27.3K | filing |
| 2026-09-08 | 2026-09-09 02:34:06.066 UTC | 2026-09-08 | 0 | Malik Fady Ibraham | Development | Exercise of derivative | 3,500 | $0.00 | — | filing |
| 2026-08-31 | 2026-09-01 02:23:39.425 UTC | 2026-08-31 | 0 | Blum Robert I | Director, CEO | Open market sale | 7,500 | $70.24 | $526.8K | filing |
| 2026-08-31 | 2026-09-01 02:23:39.425 UTC | 2026-08-31 | 0 | Blum Robert I | Director, CEO | Exercise of derivative | 7,500 | $10.60 | $79.5K | filing |
| 2026-08-31 | 2026-09-01 02:23:39.425 UTC | 2026-08-31 | 0 | Blum Robert I | Director, CEO | Exercise of derivative | 7,500 | $0.00 | — | filing |
| 2026-08-31 | 2026-09-01 02:23:45.626 UTC | 2026-08-31 | 0 | Callos Andrew | EVP, Chief Commercial Officer | Exercise of derivative | 10,000 | $0.00 | — | filing |
| 2026-08-31 | 2026-09-01 02:23:45.626 UTC | 2026-08-31 | 0 | Callos Andrew | EVP, Chief Commercial Officer | Exercise of derivative | 10,000 | $23.26 | $232.6K | filing |
| 2026-08-31 | 2026-09-01 02:23:45.626 UTC | 2026-08-31 | 0 | Callos Andrew | EVP, Chief Commercial Officer | Open market sale | 10,000 | $70.24 | $702.4K | filing |
| 2026-08-10 | 2026-08-11 02:20:15.260 UTC | 2026-08-10 | 0 | Blum Robert I | Director, CEO | Open market sale | 7,500 | $76.76 | $575.7K | filing |
| 2026-08-10 | 2026-08-11 02:20:15.260 UTC | 2026-08-10 | 0 | Blum Robert I | Director, CEO | Exercise of derivative | 7,500 | $0.00 | — | filing |
| 2026-08-10 | 2026-08-11 02:20:15.260 UTC | 2026-08-10 | 0 | Blum Robert I | Director, CEO | Exercise of derivative | 7,500 | $10.60 | $79.5K | filing |
| 2026-07-30 | 2026-07-31 02:18:04.698 UTC | 2026-07-30 | 0 | Callos Andrew | EVP, Chief Commercial Officer | Open market sale | 14,000 | $79.88 | $1.1M | filing |
| 2026-07-30 | 2026-07-31 02:18:04.698 UTC | 2026-07-30 | 0 | Callos Andrew | EVP, Chief Commercial Officer | Exercise of derivative | 14,000 | $23.26 | $325.6K | filing |
| 2026-07-30 | 2026-07-31 02:18:04.698 UTC | 2026-07-30 | 0 | Callos Andrew | EVP, Chief Commercial Officer | Exercise of derivative | 14,000 | $0.00 | — | filing |
| 2026-07-27 | 2026-07-28 02:32:42.444 UTC | 2026-07-27 | 0 | Blum Robert I | Director, President & CEO | Open market sale | 7,500 | $80.87 | $606.5K | filing |
| 2026-07-27 | 2026-07-28 02:32:42.444 UTC | 2026-07-27 | 0 | Blum Robert I | Director, President & CEO | Exercise of derivative | 7,500 | $10.60 | $79.5K | filing |
| 2026-07-27 | 2026-07-28 02:32:42.444 UTC | 2026-07-27 | 0 | Blum Robert I | Director, President & CEO | Exercise of derivative | 7,500 | $0.00 | — | filing |
| 2026-07-23 | 2026-07-26 13:42:17.467 UTC | 2026-07-21 | 2 | Malik Fady Ibraham | EVP Research & Development | Exercise of derivative | 3,500 | $0.00 | — | filing |
| 2026-07-23 | 2026-07-26 13:42:17.467 UTC | 2026-07-21 | 2 | Malik Fady Ibraham | EVP Research & Development | Open market sale | 3,500 | $80.59 | $282.1K | filing |
| 2026-07-23 | 2026-07-26 13:42:17.467 UTC | 2026-07-21 | 2 | Malik Fady Ibraham | EVP Research & Development | Exercise of derivative | 3,500 | $7.80 | $27.3K | filing |